Experimental coronavirus drug Remdesivir expected to get emergency FDA approval

Early findings from an NIH study show that the median recovery time for patients who took Remdesivir was 11 days, compared to 15 for those who took the placebo. The results are preliminary, the FDA says, but are generating excitement among health care workers.